[HTML] frontiersin.org

[HTML][HTML] Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis

F Liu, Y Yang, W Cheng, J Ma, W Zhu - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis

F Liu, Y Yang, W Cheng, J Ma… - Frontiers in Cardiovascular …, 2021 - ncbi.nlm.nih.gov
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …

Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.

F Liu, Y Yang, W Cheng, J Ma, W Zhu - Frontiers in Cardiovascular …, 2021 - europepmc.org
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …

Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis

F Liu, Y Yang, W Cheng, J Ma… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …